KMT2A and acute lymphoblastic leukemia: Furthermore, using high‐throughput combinatorial drug library screens, we explored whether prolonged low‐dose decitabine would epigenetically prime and chemo‐sensitize MLL‐rearranged ALL cells toward standard chemotherapy, as well as toward an array of other, mostly FDA‐approved compounds.